There are no results for this module. Edit the module to change the search term used to query related articles.
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
The initial agreement was announced in April 2007 and today’s agreement provides an extension to 2015. Merck has evaluated the use of Codexis enzymes extensively across programs in various stages of development, including their collaborated to develop... Full Article at Biofuels Digest
Factor in the past history that Merck (MRK) offered up to $450M for NMED-160 (now Z160). Pipeline valuation including Exalgo, Synavive, Prednisporin, Z160, Z944, and other intellectual property (e.g. cHTS Chalice technology) arguably out-values the... Full Article at Seeking Alpha
COMMERCIAL IMAGE - In this photograph released by TuneInToHepC.com/HepatitisCTocaEITema.com on Thursday, April 26, 2012, GRAMMY� winner Jon Secada meets with members of Congress as part of his participation in the Tune In to Hep C public awareness... View Photo »
We are delighted to work with Merck’s scientists to expand their understanding of the signaling pathways of the selected receptor
With the transition underway, if it's successful, this may be the lowest stock price available for investors interested in Pfizer. The price has currently been around $22, the 52 week range has been from $16 to $23. This is the lowest price available... Full Article at Seeking Alpha
Serono, a division of Merck, Darmstadt, Germany, today announced its support of an awareness campaign on thyroid disorders and possible related cardiovascular risks. The campaign is in conjunction with the fourth annual International Thyroid Awareness... Full Article at iStockAnalyst
Blood Sugar Basics Game Plan, developed by the American College of Endocrinology (ACE), with support from Merck (NYSE: MRK) (known as MSD outside the United States and Canada), is kicking off to help the nearly 26 million people in the U.S. who have... Full Article at News-Medical.net
COMMERCIAL IMAGE - In this photograph released by TuneInToHepC.com/HepatitisCTocaEITema.com on Thursday, April 26, 2012, GRAMMY� winner Jon Secada meets with Congressional Hispanic Caucus members on behalf of the Tune In to Hep C campaign in an effort... View Photo »
Merck & Co.'s ... leader received compensation valued at $13.3 million for 2011, up 41% from the year before, reflecting his ascension to the drug maker's top post and Merck's ability to exceed certain internal performance targets.
Industry Vonage belongs with the industry of Diversified Communication Services, but related industries as well as competition comes from other industries such as Telecom Services, Communication Equipment and Long Distance Carriers to just name a few. Full Article at Term Paper Warehouse
They also approved Ernst & Young as Amgen's accountant. A nonbinding "Say-on Pay" proposal, approving compensation for Amgen's executives, won 87 percent of votes cast. Sharer received $18.9 million in total compensation last year, and Bradway got $7.1... Full Article at WHAS11.com
The various dividend rates are not equal, however. Merck has the highest payout ratio of 77%, while Abbott pays at ratio of 62% of earnings. Johnson & Johnson pays at a ratio of 64% while Sanofi's payout is the lowest at only 48%. This gives you a... Full Article at Seeking Alpha
There are no results for this module. Edit this module to change the search term used to query Wikipedia
We are delighted to work with Merck’s scientists to expand their understanding of the signaling pathways of the selected receptor
Merck & Co.'s ... leader received compensation valued at $13.3 million for 2011, up 41% from the year before, reflecting his ascension to the drug maker's top post and Merck's ability to exceed certain internal performance targets.
We are excited that Kadimastem, that was established around one of our technologies, is collaborating with Merck Serono. Merck Serono has a long and successful tradition of developing products that emerged from the Weizmann Institute labs, and we hope that Kadimastem will be another link in this chain.
We are pleased to announce this agreement with Merck-Serono, a company with robust experience in drug discovery, development and marketing in the Multiple Sclerosis area
Beyond earnings, we continue to believe Merck’s late-stage pipeline updates in 2012 and 2013 represent key drivers for the stock
Regrettably, these planned measures include the closure of our headquarters in Geneva, which would result in workforce reductions and the redeployment of certain Switzerland-based functions to other Merck locations
The planned measures for Merck Serono's operations in Switzerland are needed to ensure our global competitive position in a rapidly changing market and to secure the long-term future of the company
The stock has been on a path of recovery since last November, but this has been more correlated with the dividend increase and flow into the pharma sector as a whole than a restoration of sentiment around Merck’s innovation core.
Merck is emerging from a challenging 2011
Operational results in the quarter are unlikely to change sentiment, and we believe that Merck needs to deliver on pipelines to restore enthusiasm towards the stock.
Merck's first-quarter results again demonstrated our ability to execute on our strategic plans and grow the top and bottom lines
Perhaps 500,000 or more premature American deaths may have resulted from Vioxx [my italics], a figure substantially larger than the 3,468 deaths of named individuals acknowledged by Merck during the settlement of its lawsuit. And almost no one among our political or media elites seems to know or care ab...
The decision to join forces with Shared Interest was an easy one for Merck ... We are proud to support their efforts to enable small agricultural business owners to obtain the loans, skills and technical expertise that they need, to boost health and economic empowerment in the critical part of the world...
Bob has played key roles in the successful registration of more than a dozen new drug applications worldwide, including the established oncology drugs, Tarceva and Taxol ... His wealth of experience in the regulatory affairs arena will be especially valuable to us as we and Merck determine next steps fo...
Merck’s ranking in the top 100 of Maplecroft’s CII reflects its continued commitment to greenhouse gas (GHG) emissions reductions
At Merck, we have a long history of environmental responsibility and compliance. But we know that the world's current approach to resource use is not sustainable
Die geplanten Maßnahmen für Merck Serono in der Schweiz sind notwendig, um langfristig unsere globale Wettbewerbsposition sowie unsere Zukunft in einem sich rasch ändernden Markt zu sichern
Les mesures planifiées pour les opérations de Merck Serono en Suisse sont nécessaires pour maintenir notre position concurrentielle au niveau mondial sur un marché en mutation rapide et pour assurer l'avenir à long terme de la société
Vintafolide is a promising and innovative late-stage cancer drug candidate. In addition to pursuing the lead indication of platinum-resistant ovarian cancer, Merck plans to further evaluate its potential for treatment of multiple other cancer types
To make a profit, Merck put the lives of New Yorkers in danger by misrepresenting the safety of Vioxx ... The settlement holds this pharmaceutical giant accountable for its deceptive marketing practices and ripping off our state's taxpayers. Our office will continue to root out this kind of reckless cor...
Merck now knows that no corporation is immune from being held accountable for criminal and civil violations of law and also knows why the FBI, its federal law enforcement partners, and the United States Attorney’s Office have earned a national reputation for leading the government’s effort to detect, de...
In 2004, the FBI began participating in a seven year investigation that led to Merck’s decision to plead guilty to a criminal violation of federal law related to its promotion and marketing of Vioxx and to pay nearly a billion dollars in a criminal fine and civil damages
Being at Merck grounded me. I had the common goal of still being involved in the drug and taking SAHA to approval.
At this point, it's clear that Gilead, Bristol-Myers and Abbott are among the leaders, and that current players, including Merck, are lagging and appear to be losing ground in this pursuit.
The government recognized Merck's full cooperation with its investigation, and by putting this long-standing investigation to rest, we can more fully focus on discovering, developing and providing innovative medicines and vaccines that save and improve lives around the world
There are no results for this module. Edit the module to change the search term used to query Twitter.
We found no conversations related to Merck & Company, Inc.
There are no results for this module.
A fresh, fun site featuring celeb gossip, fashion, beauty, love & sex, and health & fitness.
©Independent.ie Back to top